This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Updates to the Guidelines on Diabetes Management: Navigating and Applying the 2017 Guidelines

Updates to the Guidelines on Diabetes Management: Navigating and Applying the 2017 Guidelines



Time to Complete

1 hour


December 28, 2017


December 28, 2018
Add to Queue

Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / ABIM MOC Part II Point

An important note about ABIM MOC Part II points
Successful completion of this CME activity enables eligible participants to earn up to 1.00 ABIM-Part II Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. To claim MOC points, follow these easy steps:

Step 1: Complete all 4 questions under the "ABIM Part 2 Credit Questions" section, located at the bottom of the course evaluation form. This includes 1) attesting that our partner may submit your credits to ABIM, 2) attesting that you are ABIM board certified, 3) providing your ABIM #, and 4) providing your date of birth (MM/DD).

Step 2: Our partner, The Potomac Center for Medical Education, will send your MOC points to your ABIM account within 6-8 weeks.

If you have any questions about MOC points, please contact

Accredited Provider

Jointly provided by the Potomac Center for Medical Education and Rockpointe

Commercial Supporter

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC and by an educational grant from Lilly. For further information concerning Lilly grant funding visit

Program Description

Diabetes is seen as a “complicated disease” by clinicians, and its management is also perceived as complicated by patients. Despite management guidelines, approximately 63% of patients with diabetes are not at HbA1c goal (<7.0%) per the National Committee for Quality Assurance (NCQA). Patients with T2DM often present with comorbidities, which can further complicate antihyperglycemic treatment for both patients and clinicians. For example, despite control of standard risk factors, cardiovascular disease (CVD) remains the leading cause of death in patients with T2DM. Renal dysfunction also occurs frequently in these patients, and due to gaps in screening, it often goes undiagnosed until patients have later stage chronic kidney disease (CKD), which further increases the risk of CVD in patients with T2DM.

Updates to the Guidelines on Diabetes Management is designed to enhance clinician knowledge of the efficacy/safety profiles of available antihyperglycemic agents and explore the evidence from clinical trials and guidelines to appropriately individualize the management of patients with T2DM. The initiative will also help clinicians optimize the monitoring and treatment of associated comorbidities, while recognizing the importance of patient engagement in developing an effective diabetes care plan.

Intended Audience

This activity is intended for members of the T2DM care team, including primary care providers, internists, PAs, NPs, diabetes educators, and other healthcare providers.

Educational Objectives

This program is designed to address the following IOM competencies: provide patient-centered care and employ evidence-based practice.

At the conclusion of this activity, participants should be able to demonstrate the ability to:

  • Identify appropriate pharmacologic treatment options for individualized T2DM management using guideline- and trial-based evidence and accounting for patient presentation
  • Explain the impact of antihyperglycemic agents on cardiovascular and renal issues in patients with T2DM
  • Identify the barriers to optimal T2DM management by actively engaging patients in their T2DM management plan

Fee Information

There is no fee for this activity.

Conflict Of Interest Disclosure Policy

Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.


Prakash Deedwania, MD, FACC, FAHA, FACP, FASH
Professor of Medicine
UCSF School of Medicine
San Francisco, CA

Dr. Deedwania discloses the following:
Consultant: Amgen, Janssen
Research: Amgen, Janssen

Philip Raskin, MD, FACP, FACE, CDE
Professor of Medicine
Clifton and Betsy Robinson Chair in Biomedical Research
University of Texas Southwestern Medical Center
Dallas, TX

Dr. Raskin discloses the following:
Consultant: Intarcia Therapeutics, GlaxoSmithKline
Research: Boehringer Ingelheim

Accredited Provider Disclosure

Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Kathy Merlo, CHCP; Blair St. Amand; Lindsay Scott, PT, DPT, ATC; and Ashley Marostica, MSN, RN have nothing to disclose.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The Potomac Center for Medical Education designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Part II Point

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure of Unlabeled Use

The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.


To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For questions regarding CME credit, the post-test, or evaluation, please email

If you have any questions relating to the accreditation of this activity, please email

If you have any other questions relating to your certificate or other issues with the activity, please contact


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue